Skip to content

Clinical study of anesthesia effect of remazolam tosylate on patients undergoing day surgery

Clinical study of anesthesia effect of remazolam tosylate on patients undergoing day surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047774
Enrollment
Unknown
Registered
2021-06-26
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Day surgery anesthesia

Interventions

Control group:Anesthesia induction 2 mg/kg
maintenance 6 mg/kg/h
Experimental groupA:Anesthesia induction 6 mg/kg/h
maintenance 1mg/kg/h
Experimental groupB:Induce 12 mg/kg/h
maintain 1 mg/kg/h

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Orthopedics, ENT and ophthalmology surgery patients; 2. Aged 18 to 60 years; 3. ASA classification i-iii; 4. No obvious cardiopulmonary disease; 5. Previous chronic diseases are well controlled.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to benzodiazepines; 2. Severe cardiac and pulmonary dysfunction; 3. Chronic disease control is unstable; 4. Unhealed acute upper respiratory tract infection; 5. Patients with psychosis or poor compliance.

Design outcomes

Primary

MeasureTime frame
the depth of anesthesia;Whether body movement occurs;Tracheal extubation time;Time and quality of sedation and awakening;

Countries

China

Contacts

Public ContactHua Fuzhou
huafuzhou@126.com+86 15170238929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026